By restoring mitochondrial function at the cellular level, SS-31 addresses one of the upstream causes of nerve damage that other peptides do not directly target
Despite these promising findings, current evidence remains largely preclinical
Its not for human consumption, nor is it intended to diagnose, treat, cure, or prevent any disease
Key reasons why BPC-157 is better than many traditional joint pain treatments: No known toxicity or side effects Accelerates healing in tendons, ligaments, muscles, and joints Non-invasive and drug-free Improves vascular repair and cellular regeneration Does not interfere with other medications or long-term health While painkillers and steroids may provide short-term relief, they do not promote tissue repair
Billon 2023 (ACS Chemical Biology) Preclinical in vivo, 15-28 days, C57BL/6J mice (n = 8-10 per group)
We strive to ensure all orders are processed and delivered promptly